[go: up one dir, main page]

MY142098A - Delivery system - Google Patents

Delivery system

Info

Publication number
MY142098A
MY142098A MYPI20043438A MYPI20043438A MY142098A MY 142098 A MY142098 A MY 142098A MY PI20043438 A MYPI20043438 A MY PI20043438A MY PI20043438 A MYPI20043438 A MY PI20043438A MY 142098 A MY142098 A MY 142098A
Authority
MY
Malaysia
Prior art keywords
delivery system
vaginal cavity
internal phase
high internal
emulsion
Prior art date
Application number
MYPI20043438A
Inventor
Robert C Cuca
Thomas C Riley
Saul R Levinson
Original Assignee
Drugtech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2004/022058 external-priority patent/WO2006016869A1/en
Application filed by Drugtech Corp filed Critical Drugtech Corp
Publication of MY142098A publication Critical patent/MY142098A/en

Links

Landscapes

  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A PHARMACEUTICAL DELIVERY SYSTEM THAT RELEASES AN ACTIVE AGENT IN A CONTROLLED MANNER FOR AN EXTENDED PERIOD IN THE VAGINAL CAVITY TO TREAT OR CURE AILMENTS ASSOCIATED WITH THE VAGINAL CAVITY OR PROXIMAL AREAS. THE DELIVERY SYSTEM INCLUDES AN APPLICATOR WHICH IS COMPOSED OF A HIGH INTERNAL PHASE EMULSION, ALLOWING THE DELIVERY SYSTEM TO ADHERE TO THE MUCOSAL SURFACES OF THE BODY, PRIMARILY THE LINING OF VAGINAL CAVITY. THE DELIVERY SYSTEM CAN MAINTAIN THE HIGH INTERNAL PHASE EMULSION AT A TEMPERATURE OF 30oC(86°F) FOR AT LEAST ONE MONTH, WITHOUT DECOMPOSITION OR INSTABILITY OF THE EMULSION.
MYPI20043438A 2004-07-08 2004-08-24 Delivery system MY142098A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/022058 WO2006016869A1 (en) 2004-07-08 2004-07-08 Delivery system

Publications (1)

Publication Number Publication Date
MY142098A true MY142098A (en) 2010-09-15

Family

ID=37038132

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20043438A MY142098A (en) 2004-07-08 2004-08-24 Delivery system

Country Status (6)

Country Link
JP (1) JP3106541U (en)
IT (1) ITMI20040379U1 (en)
MY (1) MY142098A (en)
PL (1) PL114959U1 (en)
SK (1) SK4657U (en)
TW (1) TWM294946U (en)

Also Published As

Publication number Publication date
ITMI20040379U1 (en) 2004-11-04
JP3106541U (en) 2005-01-06
SK4657U (en) 2007-01-04
TWM294946U (en) 2006-08-01
PL114959U1 (en) 2006-01-09

Similar Documents

Publication Publication Date Title
IL273765A (en) Combinations and modes of administration of therapeutic agents and combination therapy
MXPA03010402A (en) 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-d) pyrimidine derivatives.
PH12021551792A1 (en) Bi-ligand drug conjugate and use thereof
BR0316157A (en) 4-Amino-5-phenyl-7-cyclohexyl-pyrrolo [2,3-d] pyrimidine derivatives
BR0306501A (en) Method for use and production of a medicated buffer
EP1521749B8 (en) PHENYL-(4-(3-PHENYL-1H-PYRAZOL-4-YL)-PYRIMIDIN-2-Yl)-AMINE DERIVATIVES
BR0014929A (en) Drug delivery device, and process for delivering a pharmaceutically active agent to a target tissue within a body
BRPI0513200A (en) use of an anti-igf-1r antibody in the preparation of a medicament for combined treatment for nonhematological malignancies
TN2018000335A1 (en) Liquid formulations of (s)-n-(5-((r)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
MX2007004862A (en) Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases.
BR112019006228A2 (en) prostate cancer treatment
EP1765452A4 (en) Delivery system
WO2006029036A3 (en) Combination therapy with glatiramer acetate and n-acetylcysteine for the treatment of multiple sclerosis
BRPI0414305A (en) oral drug delivery system
HK1255584A1 (en) Combination therapy using acamprosate and d-cycloserine
MX2007004861A (en) Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases.
ZA202101688B (en) Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain
MY142098A (en) Delivery system
BR112022003419A2 (en) Solid oral dosage form comprising naproxen and vitamin b12
PA8624501A1 (en) PIPERAZINAS DERIVED FROM UREA FOR THE TREATMENT OF ENDOMETROSIS
Glamazdin et al. Anthelmintic efficiency of medicinal forms of albendazole received on mechanochemical technologies and use of address delivery Drug Delivery System on laboratory model
JOP20180088A1 (en) Liquid formulations of (s)-n-(5-((r)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
TH84091A (en) Delivery system
YU17703A (en) New pharmaceutical composition for use on skin
TH1801006190A (en) Compounds for the production of liquid formulations for the treatment of childhood cancer